Maverick Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.6M | Buy |
1,310,605
+102,512
| +8% | +$3.33M | 0.64% | 42 |
|
|
2025
Q1 | $45.6M | Buy |
1,208,093
+6,195
| +0.5% | +$234K | 0.81% | 42 |
|
|
2024
Q4 | $98.4M | Buy |
1,201,898
+225,649
| +23% | +$18.5M | 1.77% | 23 |
|
|
2024
Q3 | $112M | Buy |
976,249
+288,341
| +42% | +$32.9M | 2.18% | 17 |
|
|
2024
Q2 | $51.9M | Buy |
687,908
+332,777
| +94% | +$25.1M | 0.99% | 32 |
|
|
2024
Q1 | $24.3M | Buy |
+355,131
| New | +$24.3M | 0.46% | 50 |
|